Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-4-3
pubmed:abstractText
Adequate relief (AR) of irritable bowel syndrome (IBS) symptoms (IBS-AR) has been used as a primary end point in many randomized controlled trials of IBS and is considered by the Rome III committee to be an acceptable primary end point. However, controversy exists on whether baseline severity confounds the effect of the treatment outcome. The aim (1) is to compare a subjective report of IBS-AR with global assessment of improvement (IBS-GAI), change in IBS symptom severity scale (IBS-SSS), and IBS quality of life (IBS-QOL); (2) to explore whether initial IBS symptom severity influences the ability of these outcome measures to detect differences post treatment; and (3) to determine whether psychological symptoms influence the sensitivity of these measures, in a randomized controlled treatment trial.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-10468696, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-10520844, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-10580921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-10744088, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-10763950, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-11485506, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-11569692, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-12692051, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-12870789, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-13688369, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-15000272, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-15082584, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-15765393, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16020489, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16233998, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16573774, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16678561, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16678567, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-16842448, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-17040359, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-17227528, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-19293789, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-19888249, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-9146781, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-9512138, http://linkedlifedata.com/resource/pubmed/commentcorrection/19293784-9602985
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1572-0241
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
912-9
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Adequate relief in a treatment trial with IBS patients: a prospective assessment.
pubmed:affiliation
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural